AbstractGenome‐scale in silico modelingMilne et al., Biotechnol. J. 2009, 4, 1653–1670Driven by advancements in high‐throughput biological technologies and the growing number of sequenced genomes, the construction of in silico models at the genome scale has provided powerful tools to investigate a vast array of biological systems and applications. Nathan Price and colleagues review comprehensively the use of such models in industrial and medical biotechnology, including biofuel generation, food production, and drug development. As such, genome‐scale models can provide a basis for rational genome‐scale engineering and synthetic biology. Genome‐scale in silico models promise to extend their application and analysis scope to become a transformative tool in biotechnology.From metagenomics to metaproteomicsTuffin et al., Biotechnol. J. 2009, 4, 1671–1683Metagenomics emerged in the late 1990s as a tool for accessing and studying the collective microbial genetic material in the environment and has been widely predicted to reach new dimensions of the protein sequence space. A decade on, researchers from South Africa see that while several novel enzyme activities and protein structures have been identified the greatest advancement has been made in the isolation of novel protein sequences, some of which have no close relatives, form deeply branched lineages and even represent novel families. However, there is much room for improvement in the methods employed that need to be addressed in order to access novel biocatalytic activities.Recombinant secondary metabolitesSchäfer et al., Biotechnol. J. 2009, 4, 1684–1703Plants produce a high diversity of natural products or secondary metabolites which have interesting biological properties and quite a number are of medicinal importance. Their functions range from the protection against herbivores and/or microbial pathogens to defend against abiotic stress, e.g. UV‐B exposure. Because the production of valuable natural products, such as the anticancer drugs paclitaxel, vinblastine or camptothecin in plants is a costly process, biotechnological alternatives to produce these alkaloids more economically become more and more important. This review provides an overview of the state of art to produce alkaloids in recombinant microorganisms, such as bacteria or yeast. In a longterm perspective, it will probably be possible to generate gene cassettes for complete pathways, which could then be used for the production of valuable natural products in bioreactors or for metabolic engineering of crop plants.
Read full abstract